Header Logo

Connection

Michael Horberg to Female

Back to Details
This is a "connection" page, showing publications Michael Horberg has written about Female.
Michael Horberg
Connection Strength
2.173
Female
  1. Do medication adherence trajectories predict clinical endpoints in a cohort with HIV and chronic comorbidities? Res Social Adm Pharm. 2026 Dec; 22(12):1119-1127.
    View in: PubMed
    Score: 0.084
  2. Validation of US CDC National Death Index mortality data, focusing on differences in race and ethnicity. BMJ Health Care Inform. 2023 Jul; 30(1).
    View in: PubMed
    Score: 0.068
  3. Life Expectancy Trends Among Integrated Health Care System Enrollees, 2014-2017. Perm J. 2021 Dec 14; 25.
    View in: PubMed
    Score: 0.061
  4. Beyond the HIV Care Continuum and Viral Suppression: Broadening the Scope of Quality Metrics for Total HIV Patient Care. AIDS Patient Care STDS. 2020 11; 34(11):461-469.
    View in: PubMed
    Score: 0.057
  5. Low Back Imaging When Not Indicated: A Descriptive Cross-System Analysis. Perm J. 2016; 20(2):25-33.
    View in: PubMed
    Score: 0.041
  6. The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System. AIDS Patient Care STDS. 2015 Nov; 29(11):582-90.
    View in: PubMed
    Score: 0.040
  7. Hepatitis C screening trends in a large integrated health system. Am J Med. 2014 May; 127(5):398-405.
    View in: PubMed
    Score: 0.035
  8. Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS. 2013 Aug; 27(8):442-9.
    View in: PubMed
    Score: 0.034
  9. Getting to normal: are we there yet? AIDS. 2013 Mar 27; 27(6):1027-8.
    View in: PubMed
    Score: 0.033
  10. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2012 Jun 01; 60(2):183-90.
    View in: PubMed
    Score: 0.032
  11. Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy. AIDS Res Hum Retroviruses. 2012 Dec; 28(12):1630-6.
    View in: PubMed
    Score: 0.031
  12. Short-term clinical outcomes among treatment-experienced HIV-positive patients with early low level viremia. AIDS Patient Care STDS. 2012 May; 26(5):253-5.
    View in: PubMed
    Score: 0.031
  13. Provision of contraceptive services to women with diabetes mellitus. J Gen Intern Med. 2012 Feb; 27(2):196-201.
    View in: PubMed
    Score: 0.030
  14. HIV quality performance measures in a large integrated health care system. AIDS Patient Care STDS. 2011 Jan; 25(1):21-8.
    View in: PubMed
    Score: 0.029
  15. Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex Transm Dis. 2010 Jan; 37(1):53-8.
    View in: PubMed
    Score: 0.027
  16. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):62-9.
    View in: PubMed
    Score: 0.027
  17. Virologic outcomes of changing enfuvirtide to raltegravir in HIV-1 patients well controlled on an enfuvirtide based regimen: 24-week results of the CHEER study. J Acquir Immune Defic Syndr. 2009 Aug 01; 51(4):367-73.
    View in: PubMed
    Score: 0.026
  18. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 Sep; 24(9):1065-72.
    View in: PubMed
    Score: 0.026
  19. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med. 2009 Mar 03; 150(5):301-13.
    View in: PubMed
    Score: 0.025
  20. Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients. HIV Clin Trials. 2008 Nov-Dec; 9(6):367-74.
    View in: PubMed
    Score: 0.025
  21. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens. AIDS Patient Care STDS. 2008 Apr; 22(4):301-12.
    View in: PubMed
    Score: 0.024
  22. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008 Mar 01; 47(3):384-90.
    View in: PubMed
    Score: 0.024
  23. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Acquir Immune Defic Syndr. 2007 Apr 15; 44(5):531-9.
    View in: PubMed
    Score: 0.022
  24. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Arch Surg. 2006 Dec; 141(12):1238-45.
    View in: PubMed
    Score: 0.022
  25. The Kaiser Permanente Research Bank as a Genomic Data Resource. JAMA Netw Open. 2026 Oct 01; 9(10):e2640691.
    View in: PubMed
    Score: 0.021
  26. Syndemic Classes of Unhealthy Alcohol Use Reveal Inequities in Alcohol-Related Consequences and HIV Care Outcomes. Alcohol Clin Exp Res (Hoboken). 2026 Sep; 50(9):e70398.
    View in: PubMed
    Score: 0.021
  27. New to cohort, not new to care: leveraging historical data in HIV clinical cohorts in the United States. Am J Epidemiol. 2026 08 05; 195(8):2287-2296.
    View in: PubMed
    Score: 0.021
  28. Long-Acting Injectable Cabotegravir HIV PrEP Uptake, Adherence, and Persistence in Two Large US Integrated Healthcare Systems. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):812-818.
    View in: PubMed
    Score: 0.021
  29. Brief Report: Mammogram Rates Among Women With and Without HIV in a Large Integrated Health Care System. J Acquir Immune Defic Syndr. 2026 Jul 01; 101(7):694-700.
    View in: PubMed
    Score: 0.021
  30. Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. Lancet HIV. 2026 May; 13(5):e297-e305.
    View in: PubMed
    Score: 0.021
  31. Changes in weight and glycemia after initiation of integrase strand transfer inhibitors among people with HIV and diabetes. AIDS. 2026 Aug 01; 40(8):1180-1189.
    View in: PubMed
    Score: 0.021
  32. Characterizing STI testing and diagnosis disparities between Asian people with HIV and other racial/ethnic subpopulations in Washington, District of Columbia: a longitudinal analysis of the DC Cohort, 2018-2023. Sex Health. 2026 Feb 05; 23(1).
    View in: PubMed
    Score: 0.020
  33. Dementia incidence and prevalence in older adults with HIV: a 23-year retrospective cohort study. AIDS. 2026 Apr 01; 40(4):486-495.
    View in: PubMed
    Score: 0.020
  34. Understanding the Impact of Antiretroviral Therapy and Other Factors on HPV Clearance in Cisgender Women With HIV/HPV Coinfections in the DC Cohort. J Acquir Immune Defic Syndr. 2025 Nov 01; 100(3):274-281.
    View in: PubMed
    Score: 0.020
  35. Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalink. Vaccine. 2025 Nov 20; 67:127873.
    View in: PubMed
    Score: 0.020
  36. Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC. J Am Acad Dermatol. 2026 01; 94(1):128-142.
    View in: PubMed
    Score: 0.020
  37. Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care. BMC Public Health. 2025 Jul 29; 25(1):2580.
    View in: PubMed
    Score: 0.020
  38. The Association of Anemia on Non-AIDS-Defining Cancer and Subsequent Survival Among People With HIV After Antiretroviral Initiation. J Acquir Immune Defic Syndr. 2025 Jun 01; 99(2):175-184.
    View in: PubMed
    Score: 0.019
  39. Excess Mortality in Persons with Concurrent HIV and Cancer Diagnoses: A Retrospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 2024 Dec 02; 33(12):1698-1705.
    View in: PubMed
    Score: 0.019
  40. The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD. J Acquir Immune Defic Syndr. 2024 Nov 01; 97(3):232-241.
    View in: PubMed
    Score: 0.019
  41. Hypertension control and risk of age-associated dementia in people with HIV infection. AIDS. 2025 Jan 01; 39(1):85-90.
    View in: PubMed
    Score: 0.019
  42. COVID-19 Incidence, Risk Factors, Impact, and Related Stigma Among a Cohort of Persons With HIV in Washington, DC. J Acquir Immune Defic Syndr. 2024 08 15; 96(5):429-438.
    View in: PubMed
    Score: 0.018
  43. Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation. AIDS Res Ther. 2024 Aug 07; 21(1):52.
    View in: PubMed
    Score: 0.018
  44. Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV. J Acquir Immune Defic Syndr. 2024 Aug; 96(4):393-398.
    View in: PubMed
    Score: 0.018
  45. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study. PLoS Med. 2024 Jan; 21(1):e1004325.
    View in: PubMed
    Score: 0.018
  46. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. PLoS One. 2023; 18(9):e0290889.
    View in: PubMed
    Score: 0.017
  47. Psychosocial impacts of the COVID-19 pandemic from a cross-sectional Survey of people living with HIV in Washington, DC. AIDS Res Ther. 2023 05 09; 20(1):27.
    View in: PubMed
    Score: 0.017
  48. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA. 2023 01 03; 329(1):52-62.
    View in: PubMed
    Score: 0.016
  49. Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. PLoS One. 2022; 17(11):e0276742.
    View in: PubMed
    Score: 0.016
  50. The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017. AIDS. 2023 02 01; 37(2):287-298.
    View in: PubMed
    Score: 0.016
  51. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. JAMA Netw Open. 2022 10 03; 5(10):e2236397.
    View in: PubMed
    Score: 0.016
  52. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022 10 01; 157(10):897-906.
    View in: PubMed
    Score: 0.016
  53. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
    View in: PubMed
    Score: 0.016
  54. Longitudinal HIV care outcomes by gender identity in the United States. AIDS. 2022 11 01; 36(13):1841-1849.
    View in: PubMed
    Score: 0.016
  55. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Netw Open. 2022 05 02; 5(5):e2211677.
    View in: PubMed
    Score: 0.016
  56. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lancet HIV. 2022 03; 9 Suppl 1:S2.
    View in: PubMed
    Score: 0.016
  57. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. AIDS. 2021 07 01; 35(8):1229-1239.
    View in: PubMed
    Score: 0.015
  58. Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):663-670.
    View in: PubMed
    Score: 0.015
  59. Association of Substance Use Disorders with Engagement in Care and Mortality among a Clinical Cohort of People with HIV in Washington, DC. AIDS Behav. 2021 Jul; 25(7):2289-2300.
    View in: PubMed
    Score: 0.014
  60. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Netw Open. 2021 02 01; 4(2):e2037512.
    View in: PubMed
    Score: 0.014
  61. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. Drug Alcohol Depend. 2021 02 01; 219:108481.
    View in: PubMed
    Score: 0.014
  62. Individual-Level and Clinic-Level Factors Associated With Achieving Glycemic Control in a Large Cohort of People With HIV in Care-Washington, DC. J Acquir Immune Defic Syndr. 2020 09 01; 85(1):113-122.
    View in: PubMed
    Score: 0.014
  63. Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system. Drug Alcohol Depend. 2020 08 01; 213:108128.
    View in: PubMed
    Score: 0.014
  64. Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data. AIDS Behav. 2020 Jun; 24(6):1784-1792.
    View in: PubMed
    Score: 0.014
  65. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Netw Open. 2020 06 01; 3(6):e207954.
    View in: PubMed
    Score: 0.014
  66. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020 04; 23(4):e25484.
    View in: PubMed
    Score: 0.014
  67. Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis. Clin Infect Dis. 2020 03 03; 70(6):1131-1138.
    View in: PubMed
    Score: 0.014
  68. Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort. Sex Transm Infect. 2020 03; 96(2):89-95.
    View in: PubMed
    Score: 0.013
  69. Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model. Am J Epidemiol. 2019 12 31; 188(12):2097-2109.
    View in: PubMed
    Score: 0.013
  70. Does increased implementation support improve community clinics' guideline-concordant care? Results of a mixed methods, pragmatic comparative effectiveness trial. Implement Sci. 2019 12 05; 14(1):100.
    View in: PubMed
    Score: 0.013
  71. Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort. J Acquir Immune Defic Syndr. 2019 11 01; 82(3):329-341.
    View in: PubMed
    Score: 0.013
  72. Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015. Obesity (Silver Spring). 2019 12; 27(12):1975-1981.
    View in: PubMed
    Score: 0.013
  73. Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S. Diabetes Care. 2019 12; 42(12):2211-2219.
    View in: PubMed
    Score: 0.013
  74. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients. J Acquir Immune Defic Syndr. 2019 09 01; 82(1):71-80.
    View in: PubMed
    Score: 0.013
  75. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial. Contemp Clin Trials. 2019 09; 84:105833.
    View in: PubMed
    Score: 0.013
  76. Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial. J Gen Intern Med. 2019 10; 34(10):2054-2061.
    View in: PubMed
    Score: 0.013
  77. A Flow-Based Model of the HIV Care Continuum in the United States. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):548-553.
    View in: PubMed
    Score: 0.011
  78. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):382-390.
    View in: PubMed
    Score: 0.011
  79. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017 Jul; 17(7):1823-1832.
    View in: PubMed
    Score: 0.011
  80. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals. AIDS. 2017 04 24; 31(7):989-993.
    View in: PubMed
    Score: 0.011
  81. Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients. J Am Heart Assoc. 2017 Apr 24; 6(4).
    View in: PubMed
    Score: 0.011
  82. Cardiometabolic Risk Factors Among 1.3 Million Adults With Overweight or Obesity, but Not Diabetes, in 10 Geographically Diverse Regions of the United States, 2012-2013. Prev Chronic Dis. 2017 03 09; 14:E22.
    View in: PubMed
    Score: 0.011
  83. First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clin Infect Dis. 2017 02 15; 64(4):459-467.
    View in: PubMed
    Score: 0.011
  84. Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr. 2016 10 01; 73(2):197-204.
    View in: PubMed
    Score: 0.011
  85. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDS. 2016 10; 30(10):463-470.
    View in: PubMed
    Score: 0.011
  86. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr. 2016 09 01; 73(1):39-46.
    View in: PubMed
    Score: 0.011
  87. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis. 2016 09 15; 214(6):862-72.
    View in: PubMed
    Score: 0.010
  88. A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. J Int AIDS Soc. 2016; 19(1):20707.
    View in: PubMed
    Score: 0.010
  89. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. Am J Epidemiol. 2015 Dec 01; 182(11):952-60.
    View in: PubMed
    Score: 0.010
  90. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med. 2015 Oct 06; 163(7):507-18.
    View in: PubMed
    Score: 0.010
  91. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016 Jan; 32(1):50-8.
    View in: PubMed
    Score: 0.010
  92. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85.
    View in: PubMed
    Score: 0.010
  93. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. AIDS Patient Care STDS. 2015 Jul; 29(7):370-8.
    View in: PubMed
    Score: 0.010
  94. Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):413-9.
    View in: PubMed
    Score: 0.010
  95. Expanding Access to Care and Improving Quality in the Mid-Atlantic States Safety-Net Clinics: Kaiser Permanente's Community Ambassador Program. Perm J. 2015; 19(2):22-7.
    View in: PubMed
    Score: 0.010
  96. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73.
    View in: PubMed
    Score: 0.010
  97. Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clin Infect Dis. 2015 Apr 15; 60(8):1278-80.
    View in: PubMed
    Score: 0.009
  98. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015 Mar 15; 60(6):941-9.
    View in: PubMed
    Score: 0.009
  99. Strong agreement of nationally recommended retention measures from the Institute of Medicine and Department of Health and Human Services. PLoS One. 2014; 9(11):e111772.
    View in: PubMed
    Score: 0.009
  100. HIV infection and incidence of ischemic stroke. AIDS. 2014 Aug 24; 28(13):1911-9.
    View in: PubMed
    Score: 0.009
  101. Complications of herpes zoster in cancer patients. Scand J Infect Dis. 2014 Jul; 46(7):528-32.
    View in: PubMed
    Score: 0.009
  102. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):160-6.
    View in: PubMed
    Score: 0.009
  103. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014 Apr; 58(8):1185-9.
    View in: PubMed
    Score: 0.009
  104. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One. 2013; 8(11):e78952.
    View in: PubMed
    Score: 0.009
  105. Use of web-based shared medical records among patients with HIV. Am J Manag Care. 2013 Apr 01; 19(4):e114-24.
    View in: PubMed
    Score: 0.008
  106. Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):356-62.
    View in: PubMed
    Score: 0.008
  107. Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients. Epidemiol Infect. 2013 Nov; 141(11):2392-402.
    View in: PubMed
    Score: 0.008
  108. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013 Feb 01; 62(2):149-63.
    View in: PubMed
    Score: 0.008
  109. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82.
    View in: PubMed
    Score: 0.008
  110. Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS. 2012 Nov 13; 26(17):2223-31.
    View in: PubMed
    Score: 0.008
  111. The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):82-90.
    View in: PubMed
    Score: 0.008
  112. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med. 2012 Sep 04; 157(5):325-35.
    View in: PubMed
    Score: 0.008
  113. The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):321-7.
    View in: PubMed
    Score: 0.008
  114. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
    View in: PubMed
    Score: 0.008
  115. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis. 2011 Sep 15; 204(6):893-901.
    View in: PubMed
    Score: 0.008
  116. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS. 2011 Sep 10; 25(14):1771-7.
    View in: PubMed
    Score: 0.008
  117. Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. Am J Epidemiol. 2011 Sep 15; 174(6):727-35.
    View in: PubMed
    Score: 0.007
  118. The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clinics. Am J Manag Care. 2011; 17(8):577-83.
    View in: PubMed
    Score: 0.007
  119. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010 Jul 17; 24(11):1765-70.
    View in: PubMed
    Score: 0.007
  120. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010 Jun 01; 50(11):1512-20.
    View in: PubMed
    Score: 0.007
  121. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15; 49(10):1582-90.
    View in: PubMed
    Score: 0.007
  122. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009 Nov 13; 23(17):2337-45.
    View in: PubMed
    Score: 0.007
  123. Predictive value of HIV-1 genotypic resistance test interpretation algorithms. J Infect Dis. 2009 Aug 01; 200(3):453-63.
    View in: PubMed
    Score: 0.006
  124. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009 Apr 30; 360(18):1815-26.
    View in: PubMed
    Score: 0.006
  125. Ensuring access to treatment for HIV infection. Clin Infect Dis. 2007 Dec 15; 45 Suppl 4:S266-74.
    View in: PubMed
    Score: 0.006
  126. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007 Apr 09; 167(7):684-91.
    View in: PubMed
    Score: 0.006
  127. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol. 2007 Apr; 36(2):294-301.
    View in: PubMed
    Score: 0.005
  128. Medication error in the care of HIV/AIDS patients: electronic surveillance, confirmation, and adverse events. Med Care. 2005 Sep; 43(9 Suppl):III63-8.
    View in: PubMed
    Score: 0.005

© 2026 Kaiser Permanente

Your Privacy Choices